ONS Voice: Alternative funding programs—don’t be fooled by promises of ‘free’ specialty cancer drugs
Alternative funding programs (AFPs) claim to help companies reduce their healthcare costs by offloading the plan’s responsibility for covering most or all specialty drugs. But many employers, patients, and healthcare professionals are learning that AFPs are harmful and adding barriers to treatment. A recent article in the ONS Voice, which is published by the Oncology … Continued